To assess the cost-effectiveness of prenatal detection of congenital cytomegalovirus (cCMV) following maternal primary infection in the first trimester within standard pregnancy follow-up or involving population-based screening (serological testing at 7 and 12 weeks of gestation), with or without secondary prevention (valaciclovir) in maternal CMV primary infection.

中文翻译：

---

倾向于在妊娠期进行巨细胞病毒血清学筛查以预防先天性感染：成本效益视角

评估在标准妊娠随访或涉及基于人群的筛查（妊娠 7 周和 12 周的血清学检测）中，在孕早期母体原发感染后产前检测先天性巨细胞病毒 (cCMV) 的成本效益，有或没有母体 CMV 原发感染的二级预防（伐昔洛韦）。